Share Email Print

Proceedings Paper

Implantable fluorescence-based glucose sensor development
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

An implantable sensor is being created that allows measurement of blood glucose through fluorescent detection of an embedded chemical assay. The sensor is based on the competitive binding reaction between the protein Concanavalin A and various saccharide molecules, specifically a glycodendrimer and glucose. Previous studies have shown the ability of an embedded chemical assay using Con A and dextran with shorter wavelength dyes to both sense changes in glucose and generate sufficient fluorescent emission to pass through the dermal tissue. However, due to the chemical constituents of the assay, multivalent binding was evident resulting in poor spectral change due to glucose within the biological range. Use of a glycodendrimer and longer wavelength dyes has improved the sensor’s spectral change due to glucose and the overall signal to noise ratio of the sensor. In this work, a description of this sensor and the results obtained from it will be presented showing a large dynamic range of fluorescence with glucose.

Paper Details

Date Published: 7 March 2005
PDF: 6 pages
Proc. SPIE 5702, Optical Diagnostics and Sensing V, (7 March 2005); doi: 10.1117/12.585297
Show Author Affiliations
Bennett L. Ibey, Texas A&M Univ. (United States)
Vamsi K. Yadavalli, The Pennsylvania State Univ. (United States)
Hope R. Thomas, Texas A&M Univ. (United States)
Rebecca M. Rounds, Texas A&M Univ. (United States)
Michael V. Pishko, The Pennsylvania State Univ. (United States)
Gerard L. Cote, Texas A&M Univ. (United States)

Published in SPIE Proceedings Vol. 5702:
Optical Diagnostics and Sensing V
Alexander V. Priezzhev; Gerard L. Cote, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?